Polycythemia Vera Treatments
Find Polycythemia Vera Treatments
Medications for Polycythemia Vera
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Polycythemia Vera.
Found 1 Approved Drug for Polycythemia Vera
Ruxolitinib
Brand Names
Jakafi, Opzelura
Ruxolitinib
Brand Names
Jakafi, Opzelura
Form: Cream, Tablet
Method of administration: Oral, Topical
FDA approval date: November 16, 2011
Classification: Janus Kinase Inhibitor
Jakafi is a kinase inhibitor indicated for treatment of: intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis in adults.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances